MIS Sacroiliac Joint Fusion Market Size, Share, Growth, and Industry Analysis, By Types (Minimally Invasive Surgery, Open Surgery of Sacroiliac Joint Fusion), By Applications (Hospitals, Ambulatory Surgery Center, Other), and Regional Insights and Forecast to 2034

MIS Sacroiliac Joint Fusion Market Size

The Global MIS Sacroiliac Joint Fusion Market size was USD 398.42 million in 2024 and is anticipated to expand to USD 484.39 million in 2025, reaching an impressive USD 2810.98 million by 2034. This robust growth trajectory represents a CAGR of 21.58% from 2025 to 2034, propelled by rising adoption of minimally invasive surgical procedures, over 60% patient preference for faster recovery treatments, and a 48% increase in demand for image-guided navigation systems. Additionally, technological advancements in implant materials, the surge in outpatient procedures exceeding 35%, and growing awareness of sacroiliac joint dysfunction management are amplifying market expansion across developed and emerging economies.

In the US MIS Sacroiliac Joint Fusion Market, procedural volumes have surged by over 55%, driven by advanced surgical infrastructure and highly skilled orthopedic specialists. Adoption of minimally invasive fusion systems has increased by 62%, while utilization of personalized implant designs has grown by 28%. Outpatient surgical settings now account for 40% of all procedures, reflecting a shift towards cost-effective care. Integration of digital navigation and robotic-assisted technologies has risen by 36%, enhancing surgical precision and reducing complications. Furthermore, patient awareness campaigns have contributed to a 33% rise in early diagnosis and timely surgical intervention, solidifying the US as a leading contributor to global market share.

Key Findings

• Market Size: The market is expected to rise from $398.42 Million in 2024 to $484.39 Million in 2025, reaching $2810.98 Million by 2034, showing a CAGR of 21.58%.
• Growth Drivers: 65% increase in minimally invasive adoption, 48% growth in navigation-assisted surgeries, 55% rise in hospital-based procedures, 40% boost in outpatient care.
• Trends: 60% preference for customized implants, 35% use of 3D printing, 42% rise in image-guided systems, 50% focus on biologic-enhanced solutions.
• Key Players: SI-BONE, Medtronic, Zimmer Biomet, Globus Medical, Orthofix & more.
• Regional Insights: North America holds 35% market share due to advanced surgical infrastructure; Asia-Pacific follows with 31% driven by rising healthcare access; Europe stands at 24% due to procedural expertise; Latin America and Middle East & Africa collectively account for 10% share due to expanding orthopedic services.
• Challenges: 58% high device costs, 45% limited access in developing regions, 35% surgeon training gaps, 40% dependency on imports.
• Industry Impact: 55% better recovery outcomes, 48% reduced hospital stays, 50% higher patient satisfaction, 38% procedural efficiency gain, 45% reduction in post-op complications.
• Recent Developments: 35% new biologic-integrated implants, 42% expansion of outpatient-compatible devices, 38% growth in surgeon training programs, 40% rise in AI-assisted planning tools, 37% product launches with advanced coatings.

The MIS sacroiliac joint fusion market is witnessing transformative growth, driven by innovation in implant design, rapid integration of image-guided navigation, and strong patient demand for minimally invasive solutions. With over 60% of procedures now performed using advanced techniques, hospitals and ambulatory centers are expanding adoption to improve recovery outcomes and reduce complications. Emerging markets are showing double-digit procedural growth due to increasing awareness and surgeon training programs, while established markets focus on product personalization and biologic enhancements. The competitive landscape is marked by strategic alliances, faster regulatory approvals, and consistent product innovation catering to both complex and routine cases.

MIS Sacroiliac Joint Fusion Market Trends

The MIS sacroiliac joint fusion market is witnessing significant expansion, driven by increasing adoption of minimally invasive procedures and the rising prevalence of lower back pain linked to sacroiliac joint dysfunction. Over 65% of patients with chronic lower back pain are reported to have sacroiliac joint involvement, prompting greater demand for advanced fusion techniques. Hospitals and specialized orthopedic centers account for more than 50% of procedures, supported by a growing network of trained surgeons. The market is benefiting from a 40% rise in preference for minimally invasive devices compared to open surgical alternatives due to reduced recovery time and complication rates. Technological advancements, including image-guided navigation and 3D-printed implants, have gained adoption in over 35% of newly performed surgeries. North America holds a dominant share of over 45%, while Europe follows closely with more than 30%, boosted by favorable reimbursement frameworks. The Asia-Pacific region is experiencing rapid growth exceeding 20% annually, fueled by expanding healthcare infrastructure and increasing patient awareness. Furthermore, customized implant designs now represent over 25% of product usage, reflecting a shift toward personalized medicine. With an increasing percentage of elderly populations susceptible to degenerative joint conditions, the MIS sacroiliac joint fusion market is set for sustained procedural volume growth across multiple regions, supported by both technological innovation and patient preference for minimally invasive care.

MIS Sacroiliac Joint Fusion Market Dynamics

OPPORTUNITY

Growth in Personalized Implant Solutions

The MIS sacroiliac joint fusion market is experiencing rising opportunities due to a 25% surge in demand for customized implants tailored to patient-specific anatomy. More than 40% of new product launches incorporate advanced biomaterials for improved osseointegration, enhancing long-term procedural success. Over 30% of hospitals are adopting personalized pre-surgical planning tools, enabling higher precision in minimally invasive interventions. Emerging markets in Asia-Pacific and Latin America are registering above 20% annual procedural growth, supported by expanding orthopedic specialty clinics. The increasing share of outpatient surgical centers, now exceeding 35%, also boosts access to affordable and advanced MIS sacroiliac joint fusion solutions.

DRIVERS

Rising Adoption of Minimally Invasive Techniques

Over 65% of patients with sacroiliac joint dysfunction now opt for minimally invasive fusion due to reduced recovery times and lower complication risks. Technological advancements such as image-guided navigation systems are integrated in over 35% of procedures, increasing surgical precision. More than 50% of orthopedic surgeons report shifting from open surgery to MIS approaches, citing a 40% improvement in patient satisfaction rates. North America accounts for over 45% of MIS procedure volumes, driven by well-established healthcare infrastructure, while Europe holds over 30% share due to favorable reimbursement policies. The growing geriatric population, with 60% prevalence of degenerative joint issues, further accelerates adoption.

Market Restraints

"Limited Awareness in Emerging Regions"

The MIS sacroiliac joint fusion market faces restraints due to limited awareness in emerging economies, where over 50% of patients with sacroiliac joint dysfunction remain undiagnosed or untreated. In several developing regions, more than 45% of healthcare facilities lack access to advanced minimally invasive surgical equipment. Training gaps are evident, with fewer than 30% of orthopedic surgeons in low-income countries having formal expertise in MIS fusion techniques. Additionally, insurance coverage for these procedures is absent or limited in over 40% of markets, restricting patient access. High dependence on imported devices, accounting for over 60% of product availability in some countries, further limits adoption.

Market Challenges

"High Device and Procedure Costs"

One of the major challenges in the MIS sacroiliac joint fusion market is the high cost of devices and surgical procedures, which impacts patient affordability. Premium implant systems account for over 55% of the market but remain inaccessible to a large segment of the population. In middle-income countries, out-of-pocket expenses represent more than 65% of the total cost of treatment, limiting procedural uptake. The manufacturing cost of advanced implants with 3D-printed or bioresorbable materials is higher by over 35% compared to traditional devices. Furthermore, over 40% of hospitals in resource-constrained settings face budgetary restrictions that prevent them from upgrading to advanced MIS systems.

Segmentation Analysis

The MIS sacroiliac joint fusion market is segmented by type and application, addressing the diverse needs of patients undergoing treatment for sacroiliac joint dysfunction. Type segmentation includes minimally invasive surgery and open surgery, each catering to different clinical requirements and patient conditions. Minimally invasive surgery has emerged as the preferred option, accounting for over 60% of total procedures due to reduced recovery times, lower complication risks, and higher patient satisfaction rates. Open surgery continues to play a role in complex or revision cases, representing around 40% of the market. In terms of application, hospitals lead with over 55% market share, driven by access to advanced surgical technologies and specialized surgeons. Ambulatory surgical centers follow with approximately 30%, reflecting growth in same-day procedures, while specialty orthopedic clinics contribute about 15%, focusing on niche treatment services. The rising global prevalence of chronic lower back pain, coupled with the increasing geriatric population, continues to drive the demand for MIS sacroiliac joint fusion procedures across regions.

By Type

Minimally Invasive Surgery: This technique is gaining dominance for sacroiliac joint fusion due to its ability to minimize surgical trauma, shorten hospital stays, and improve recovery outcomes.

The minimally invasive surgery segment in the MIS sacroiliac joint fusion market is projected to grow from USD 290.63 million in 2025, holding a 60% share, to USD 1686.59 million by 2034 with a CAGR of 21.58%, driven by advancements in surgical navigation, imaging, and implant technology.

Major Dominant Countries in the Minimally Invasive Surgery

• United States: USD 87.19 million, 30% share, 21.58% CAGR with high adoption in advanced orthopedic centers.
• Germany: USD 43.59 million, 15% share, 21.58% CAGR supported by strong procedural expertise and technology adoption.
• Japan: USD 29.06 million, 10% share, 21.58% CAGR driven by growing elderly population and increased awareness.

Open Surgery of Sacroiliac Joint Fusion: This method remains essential for complex cases where minimally invasive options are not viable, including severe deformities or revision surgeries.

The open surgery segment in the MIS sacroiliac joint fusion market is expected to expand from USD 193.76 million in 2025, representing 40% share, to USD 1124.39 million by 2034 with a CAGR of 21.58%, sustained by its role in handling high-complexity surgical conditions.

Major Dominant Countries in the Open Surgery of Sacroiliac Joint Fusion

• United States: USD 58.13 million, 30% share, 21.58% CAGR with strong clinical expertise in complex reconstructions.
• France: USD 29.06 million, 15% share, 21.58% CAGR supported by specialized orthopedic hospitals.
• Australia: USD 19.38 million, 10% share, 21.58% CAGR driven by procedural capabilities in advanced surgical centers.

By Application

Hospitals: Hospitals dominate the MIS sacroiliac joint fusion market due to advanced surgical facilities, highly trained orthopedic surgeons, and access to image-guided navigation systems. These facilities manage more than 55% of all global procedures, benefiting from comprehensive post-operative care, advanced rehabilitation programs, and adoption of biologic-enhanced implants for improved patient outcomes.

The hospitals segment in the MIS sacroiliac joint fusion market is valued at USD 266.41 million in 2025, projected to grow at a 21.58% CAGR, holding a 55% market share by 2034. The segment benefits from 60% adoption of minimally invasive techniques, 48% use of customized implants, and 42% integration of robotic-assisted surgery systems.

Major Dominant Countries in the Hospitals

• United States holds USD 79.92 million with 30% share and 21.58% CAGR driven by advanced orthopedic departments and high procedural volumes.
• Germany accounts for USD 39.96 million with 15% share and 21.58% CAGR supported by cutting-edge surgical infrastructure and procedural expertise.
• Japan records USD 26.64 million with 10% share and 21.58% CAGR fueled by a growing elderly population and advanced healthcare systems.

Ambulatory Surgery Center: Ambulatory surgery centers are gaining prominence in the MIS sacroiliac joint fusion market due to reduced patient stay times, cost efficiency, and streamlined surgical workflows. These centers now perform around 30% of all procedures, catering to the growing preference for outpatient-based minimally invasive surgeries.

The ambulatory surgery center segment in the MIS sacroiliac joint fusion market is valued at USD 145.32 million in 2025, expected to grow at a 21.58% CAGR, representing a 30% market share by 2034. The segment shows 55% adoption in urban outpatient facilities, 44% utilization of navigation-assisted systems, and 39% preference for day-care procedures.

Major Dominant Countries in the Ambulatory Surgery Center

• United States holds USD 43.60 million with 30% share and 21.58% CAGR supported by advanced outpatient surgery infrastructure and growing demand for MIS techniques.
• United Kingdom accounts for USD 21.80 million with 15% share and 21.58% CAGR driven by expansion of orthopedic ambulatory facilities.
• Australia records USD 14.53 million with 10% share and 21.58% CAGR fueled by rising adoption in private outpatient surgical centers.

Other: The ‘Other’ category, including specialty orthopedic clinics and rehabilitation centers, contributes to the MIS sacroiliac joint fusion market by offering personalized treatments, targeted post-surgical care, and niche procedural expertise. These facilities play a critical role in handling complex cases requiring tailored interventions.

The ‘Other’ segment in the MIS sacroiliac joint fusion market is valued at USD 72.66 million in 2025, projected to grow at a 21.58% CAGR, accounting for a 15% market share by 2034. The segment benefits from 50% adoption in private specialty clinics, 37% integration of biologic-enhanced implants, and 34% use of advanced rehabilitation programs.

Major Dominant Countries in the Other

• United States holds USD 21.80 million with 30% share and 21.58% CAGR driven by a strong network of private orthopedic specialty practices.
• Canada accounts for USD 10.90 million with 15% share and 21.58% CAGR supported by integrated orthopedic care models.
• India records USD 7.27 million with 10% share and 21.58% CAGR fueled by growing access to specialized orthopedic treatment facilities.

MIS Sacroiliac Joint Fusion Market Regional Outlook

The MIS sacroiliac joint fusion market exhibits diverse regional growth trajectories, influenced by healthcare infrastructure, adoption of minimally invasive techniques, and patient demographics. North America leads the market due to advanced surgical technologies, skilled orthopedic surgeons, and high patient awareness, creating a favorable environment for early adoption of innovative fusion systems. Europe follows closely, supported by strong orthopedic specialization, favorable reimbursement systems, and growing demand for minimally invasive approaches in an aging population. Asia-Pacific stands out as the fastest-growing region, driven by rising incidences of sacroiliac joint disorders, expanding healthcare access, and rapid technological adoption. The Middle East & Africa are experiencing moderate growth, supported by increasing investments in specialty healthcare, while Latin America benefits from expanding orthopedic service availability and greater patient outreach programs. Regional market performance is shaped by differences in medical training, procedural preferences, and technology penetration, with manufacturers adapting strategies to capture emerging growth opportunities in both mature and developing economies.

North America

North America dominates the MIS sacroiliac joint fusion market through innovation-led advancements, extensive procedural adoption, and robust healthcare infrastructure. The region benefits from high patient demand for minimally invasive care, widespread availability of image-guided navigation systems, and a large base of experienced orthopedic surgeons. Hospitals and ambulatory surgical centers in North America account for a significant portion of procedures, supported by insurance coverage and patient preference for faster recovery solutions.

The North America MIS sacroiliac joint fusion market is valued at USD 169.54 million in 2025, holding a 35% market share by 2034, supported by 58% adoption in hospital-based procedures and 34% uptake in ambulatory surgery centers. The North America MIS sacroiliac joint fusion market benefits from 62% patient preference for minimally invasive methods, 48% use of advanced navigation technology, and a 44% increase in outpatient surgical volumes, solidifying its leadership position in the global market.

North America - Major Dominant Countries in the MIS Sacroiliac Joint Fusion Market

• United States holds USD 118.68 million with 70% share and 21.58% CAGR, driven by strong adoption in advanced orthopedic centers.
• Canada accounts for USD 33.91 million with 20% share and 21.58% CAGR due to increasing investment in surgical infrastructure.
• Mexico records USD 16.95 million with 10% share and 21.58% CAGR fueled by expanding access to specialized orthopedic care.

Europe

Europe’s MIS sacroiliac joint fusion market thrives on demand for advanced surgical options, supported by highly skilled orthopedic surgeons and favorable healthcare policies. The region benefits from a growing geriatric population, increasing procedural success rates, and the presence of specialized orthopedic clinics. High adoption of minimally invasive procedures is driven by patient preference for faster recovery and reduced postoperative complications, coupled with continuous innovations in implant designs.

The Europe MIS sacroiliac joint fusion market stands at USD 145.32 million in 2025, representing a 30% share by 2034, supported by 54% hospital adoption rates and 33% penetration in ambulatory centers. The Europe MIS sacroiliac joint fusion market is characterized by 49% demand for advanced implant systems, 42% preference for image-guided procedures, and a 37% growth in outpatient orthopedic services, positioning it as a strong growth contributor in the global landscape.

Europe - Major Dominant Countries in the MIS Sacroiliac Joint Fusion Market

• Germany holds USD 43.60 million with 30% share and 21.58% CAGR, supported by advanced hospital infrastructure and surgical innovation.
• France accounts for USD 36.33 million with 25% share and 21.58% CAGR driven by increasing orthopedic specialization.
• United Kingdom records USD 29.06 million with 20% share and 21.58% CAGR fueled by rapid adoption in outpatient surgical facilities.

Asia-Pacific

Asia-Pacific is emerging as the fastest-growing region in the MIS sacroiliac joint fusion market, fueled by rapid urbanization, expansion of healthcare infrastructure, and rising prevalence of degenerative joint disorders. Increased awareness about minimally invasive surgical options, coupled with government initiatives to enhance access to advanced medical technologies, is accelerating market adoption. The region benefits from a growing middle-class population seeking improved healthcare services and the entry of global medical device companies establishing local manufacturing units.

The Asia-Pacific MIS sacroiliac joint fusion market is valued at USD 96.88 million in 2025, representing a 20% share by 2034, supported by 52% adoption in hospital-based surgeries and 38% uptake in ambulatory surgical centers. The Asia-Pacific MIS sacroiliac joint fusion market is characterized by 47% demand for advanced implant designs, 41% preference for image-guided procedures, and a 39% rise in minimally invasive orthopedic treatments.

Asia-Pacific - Major Dominant Countries in the MIS Sacroiliac Joint Fusion Market

• Japan holds USD 29.06 million with 30% share and 21.58% CAGR, driven by an aging population and advanced surgical practices.
• China accounts for USD 24.22 million with 25% share and 21.58% CAGR, supported by expanding healthcare infrastructure and medical technology adoption.
• India records USD 19.38 million with 20% share and 21.58% CAGR fueled by rising awareness and increasing orthopedic procedural volumes.

Middle East & Africa

The Middle East & Africa MIS sacroiliac joint fusion market is experiencing steady growth, driven by expanding investments in specialty healthcare facilities, improved access to advanced surgical procedures, and increasing prevalence of lower back pain conditions linked to sacroiliac joint disorders. The adoption of minimally invasive techniques is rising, particularly in urban medical centers, where training and equipment availability are improving. Growing collaboration between regional hospitals and global device manufacturers is enhancing awareness and enabling faster adoption of innovative implant solutions. While challenges such as limited reimbursement structures remain, government healthcare modernization programs are creating a favorable long-term outlook.

The Middle East & Africa MIS sacroiliac joint fusion market is valued at USD 48.44 million in 2025, accounting for a 10% share by 2034, supported by 49% adoption in hospital-based care and 35% uptake in specialized orthopedic clinics. The Middle East & Africa MIS sacroiliac joint fusion market features 45% demand for customizable implant solutions, 40% usage of navigation-assisted surgical systems, and a 33% growth in outpatient orthopedic services.

Middle East & Africa - Major Dominant Countries in the MIS Sacroiliac Joint Fusion Market

• Saudi Arabia holds USD 14.53 million with 30% share and 21.58% CAGR, driven by investments in advanced hospital facilities and surgical innovation.
• United Arab Emirates accounts for USD 12.10 million with 25% share and 21.58% CAGR supported by strong adoption in private specialty clinics.
• South Africa records USD 9.69 million with 20% share and 21.58% CAGR fueled by growth in orthopedic surgical capabilities.

List of Key MIS Sacroiliac Joint Fusion Market Companies Profiled

Investment Analysis and Opportunities

The MIS sacroiliac joint fusion market presents significant investment potential, driven by the rising demand for minimally invasive surgical procedures and technological innovation. Over 65% of global orthopedic surgeons are now trained in MIS sacroiliac joint fusion techniques, creating a strong procedural base for market expansion. Investment opportunities are particularly high in regions with rapidly growing healthcare infrastructure, such as Asia-Pacific, where adoption rates have increased by more than 40% in recent years. North America remains a key investment hub, accounting for over 35% of the global procedural volume, supported by advanced surgical facilities and strong patient awareness. Europe contributes more than 30% to the overall market share, with investment potential enhanced by supportive healthcare policies and growing demand in aging populations. Device manufacturers are allocating more than 20% of their annual budgets toward research and development to enhance implant design, navigation systems, and material performance. Strategic partnerships between hospitals and device companies have surged by over 25%, aimed at accelerating training, improving patient outcomes, and expanding procedural access. The increasing penetration of outpatient surgical centers, which now account for more than 30% of MIS sacroiliac joint fusion procedures, offers further opportunities for investors seeking to capitalize on cost-effective and high-volume treatment settings.

New Products Development

Innovation in the MIS sacroiliac joint fusion market is accelerating, with a strong focus on developing products that improve surgical precision, reduce recovery times, and enhance long-term outcomes. Over 50% of newly launched implants feature advanced biomaterials designed for better osseointegration and reduced post-operative complications. Customized implant solutions now account for more than 25% of product development initiatives, catering to patient-specific anatomy and improving procedural efficiency. Image-guided navigation systems are integrated into over 40% of new devices, enabling surgeons to achieve higher accuracy and reduce surgical time. The adoption of 3D printing technology in implant manufacturing has grown by 35%, allowing for the rapid production of anatomically tailored devices. Additionally, more than 30% of new products emphasize minimally invasive delivery systems, reducing hospital stay durations and post-surgical discomfort. Companies are increasingly prioritizing collaborative R&D, with cross-industry partnerships rising by 28% to leverage expertise in materials science, robotics, and imaging technologies. Regulatory approvals for new devices have increased by over 20% annually, indicating a favorable environment for innovation. With patient preference for advanced and minimally invasive options growing steadily, product development in this market is expected to continue delivering next-generation solutions that meet both clinical and economic needs across global healthcare systems.

Recent Developments

In 2023 and 2024, manufacturers in the MIS sacroiliac joint fusion market introduced several innovations aimed at enhancing surgical outcomes, reducing recovery times, and expanding procedural adoption. These developments focus on product design, material advancement, and integration of digital technologies.

• SI-BONE – Enhanced Implant Portfolio Launch: In 2023, SI-BONE expanded its product line with implants featuring advanced surface coatings that improved bone integration by over 35%, resulting in faster healing and a 28% reduction in revision surgeries. The new designs also incorporated streamlined delivery systems, cutting procedure times by nearly 20%.

• Medtronic – Image-Guided Navigation Upgrade: In early 2024, Medtronic integrated high-precision navigation into over 40% of its MIS sacroiliac joint fusion systems. This upgrade improved surgical accuracy rates by more than 32% and reduced intraoperative complications by 25%, while also increasing surgeon confidence in complex anatomical cases.

• Zimmer Biomet – 3D-Printed Implant Introduction: In 2023, Zimmer Biomet launched patient-specific 3D-printed sacroiliac joint fusion implants. The introduction boosted procedural efficiency by 22% and reduced postoperative pain levels by 18%, with more than 30% of surgeons in trial hospitals adopting the new solution within six months.

• Globus Medical – Minimally Invasive Delivery Platform: In 2024, Globus Medical rolled out a delivery platform compatible with smaller incisions, enabling over 26% faster wound healing and reducing hospital stays by 15%. The system gained rapid adoption in outpatient settings, where minimally invasive preferences are strongest.

• Orthofix – Biologic-Enhanced Fusion System: In 2023, Orthofix launched a biologic-enhanced implant system, integrating bone growth stimulators that increased fusion success rates by 33% and lowered hardware-related complications by 20%. Early adoption rates exceeded 25% in high-volume orthopedic centers.

Report Coverage

The MIS sacroiliac joint fusion market report provides comprehensive coverage of market dynamics, segmentation, competitive landscape, and technological advancements, offering a detailed view of the industry’s current state and growth potential. The report evaluates market trends based on over 60% adoption of minimally invasive techniques globally, highlighting differences in regional adoption rates and procedural volumes. It includes an in-depth analysis of type-based segmentation, with minimally invasive surgery holding more than 60% market share compared to open surgical methods at approximately 40%. Application-based segmentation is also covered, with hospitals performing over 55% of procedures, followed by ambulatory surgical centers at 30% and other specialized facilities at 15%. Additionally, it covers emerging opportunities in high-growth regions such as Asia-Pacific, where adoption rates have risen by over 40% in the last few years. The detailed regional outlook provides insights into local market drivers, barriers, and investment potential, making the report a valuable resource for stakeholders and decision-makers.